{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:44:21Z","timestamp":1770137061439,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T00:00:00Z","timestamp":1395014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-196","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T12:04:16Z","timestamp":1395057856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis"],"prefix":"10.1186","volume":"14","author":[{"given":"Xuliang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenshui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cailing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoting","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,17]]},"reference":[{"issue":"9669","key":"5237_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B: Renal cell carcinoma. Lancet. 2009, 373 (9669): 1119-1132. 10.1016\/S0140-6736(09)60229-4.","journal-title":"Lancet"},{"issue":"5","key":"5237_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1442-2042.2009.02302.x","volume":"16","author":"A Lopez-Beltran","year":"2009","unstructured":"Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R: 2009 update on the classification of renal epithelial tumors in adults. Int J Urol. 2009, 16 (5): 432-443. 10.1111\/j.1442-2042.2009.02302.x.","journal-title":"Int J Urol"},{"issue":"2","key":"5237_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11523-010-0149-2","volume":"5","author":"B Basu","year":"2010","unstructured":"Basu B, Eisen T: Perspectives in drug development for metastatic renal cell cancer. Target Oncol. 2010, 5 (2): 139-156. 10.1007\/s11523-010-0149-2.","journal-title":"Target Oncol"},{"issue":"5","key":"5237_CR4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/cncr.21254","volume":"104","author":"V Ficarra","year":"2005","unstructured":"Ficarra V, Schips L, Guille F, Li G, De La Taille A, Prayer Galetti T, Cindolo L, Novara G, Zigeuner RE, Bratti E, Tostain J, Altieri V, Abbou CC, Artibani W, Patard JJ: Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer. 2005, 104 (5): 968-974. 10.1002\/cncr.21254.","journal-title":"Cancer"},{"issue":"1","key":"5237_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/14737159.9.1.75","volume":"9","author":"A Mohammed","year":"2009","unstructured":"Mohammed A, Shergill I, Little B: Management of metastatic renal cell carcinoma: current trends. Expert Rev Mol Diagn. 2009, 9 (1): 75-83. 10.1586\/14737159.9.1.75.","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"5237_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan WM, Srinivasan R, Schmidt LS: The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol. 2010, 7 (5): 277-285. 10.1038\/nrurol.2010.47.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"5237_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/path.2689","volume":"221","author":"MM Baldewijns","year":"2010","unstructured":"Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruine AP: VHL and HIF signalling in renal cell carcinogenesis. J Pathol. 2010, 221 (2): 125-138. 10.1002\/path.2689.","journal-title":"J Pathol"},{"issue":"2","key":"5237_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.eururo.2012.09.054","volume":"63","author":"S Sudarshan","year":"2013","unstructured":"Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM: Metabolism of kidney cancer: from the lab to clinical practice. Eur Urol. 2013, 63 (2): 244-251. 10.1016\/j.eururo.2012.09.054.","journal-title":"Eur Urol"},{"issue":"1","key":"5237_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E: Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005, 7 (1): 77-85. 10.1016\/j.ccr.2004.11.022.","journal-title":"Cancer Cell"},{"issue":"13","key":"5237_CR10","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-13-0304","volume":"19","author":"WM Linehan","year":"2013","unstructured":"Linehan WM, Rouault TA: Molecular pathways: Fumarate hydratase-deficient kidney cancer\u2013targeting the Warburg effect in cancer. Clin Cancer Res. 2013, 19 (13): 3345-3352. 10.1158\/1078-0432.CCR-13-0304.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5237_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.semcancer.2012.06.002","volume":"23","author":"WM Linehan","year":"2013","unstructured":"Linehan WM, Ricketts CJ: The metabolic basis of kidney cancer. Semin Cancer Biol. 2013, 23 (1): 46-55. 10.1016\/j.semcancer.2012.06.002.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"5237_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale JW: Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer. 2013, 13 (8): 572-583. 10.1038\/nrc3557.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"5237_CR13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/ijc.23318","volume":"122","author":"LE Moore","year":"2008","unstructured":"Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC, Zaridze D, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Yeager M, Chanock S, Garcia-Closas M, Rothman N, Chow WH, Brennan P: Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer. 2008, 122 (8): 1710-1715.","journal-title":"Int J Cancer"},{"issue":"10","key":"5237_CR14","doi-asserted-by":"publisher","first-page":"e26165","DOI":"10.1371\/journal.pone.0026165","volume":"6","author":"TM Gibson","year":"2011","unstructured":"Gibson TM, Brennan P, Han S, Karami S, Zaridze D, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Slamova A, Pfeiffer RM, Stolzenberg-Solomon RZ, Mayne ST, Yeager M, Chanock S, Rothman N, Chow WH, Rosenberg PS, Boffetta P, Moore LE: Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer risk. PLoS One. 2011, 6 (10): e26165-10.1371\/journal.pone.0026165.","journal-title":"PLoS One"},{"issue":"4","key":"5237_CR15","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1378\/chest.07-0622","volume":"132","author":"AK Greenberg","year":"2007","unstructured":"Greenberg AK, Rimal B, Felner K, Zafar S, Hung J, Eylers E, Phalan B, Zhang M, Goldberg JD, Crawford B, Rom WN, Naidich D, Merali S: S-adenosylmethionine as a biomarker for the early detection of lung cancer. Chest. 2007, 132 (4): 1247-1252. 10.1378\/chest.07-0622.","journal-title":"Chest"},{"issue":"8","key":"5237_CR16","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1158\/1055-9965.EPI-11-0359","volume":"20","author":"S de Vogel","year":"2011","unstructured":"de Vogel S, Schneede J, Ueland PM, Vollset SE, Meyer K, Fredriksen A, Midttun O, Bjorge T, Kampman E, Bretthauer M, Hoff G: Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2011, 20 (8): 1726-1735. 10.1158\/1055-9965.EPI-11-0359.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"5237_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.alcohol.2005.03.011","volume":"35","author":"SC Lu","year":"2005","unstructured":"Lu SC, Mato JM: Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol. 2005, 35 (3): 227-234. 10.1016\/j.alcohol.2005.03.011.","journal-title":"Alcohol"},{"issue":"15","key":"5237_CR18","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1096\/fj.00-0121com","volume":"14","author":"ER Garcia-Trevijano","year":"2000","unstructured":"Garcia-Trevijano ER, Latasa MU, Carretero MV, Berasain C, Mato JM, Avila MA: S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver. FASEB J. 2000, 14 (15): 2511-2518. 10.1096\/fj.00-0121com.","journal-title":"FASEB J"},{"issue":"5","key":"5237_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2217\/epi.10.44","volume":"2","author":"H Hashimoto","year":"2010","unstructured":"Hashimoto H, Vertino PM, Cheng X: Molecular coupling of DNA methylation and histone methylation. Epigenomics. 2010, 2 (5): 657-669. 10.2217\/epi.10.44.","journal-title":"Epigenomics"},{"issue":"5","key":"5237_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009, 10 (5): 295-304. 10.1038\/nrg2540.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"5237_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/hep.22231","volume":"47","author":"AI Ara","year":"2008","unstructured":"Ara AI, Xia M, Ramani K, Mato JM, Lu SC: S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology. 2008, 47 (5): 1655-1666. 10.1002\/hep.22231.","journal-title":"Hepatology"},{"issue":"13","key":"5237_CR22","doi-asserted-by":"publisher","first-page":"9784","DOI":"10.1074\/jbc.M002347200","volume":"276","author":"AB Halim","year":"2001","unstructured":"Halim AB, LeGros L, Chamberlin ME, Geller A, Kotb M: Regulation of the human MAT2A gene encoding the catalytic alpha 2 subunit of methionine adenosyltransferase, MAT II: gene organization, promoter characterization, and identification of a site in the proximal promoter that is essential for its activity. J Biol Chem. 2001, 276 (13): 9784-9791. 10.1074\/jbc.M002347200.","journal-title":"J Biol Chem"},{"issue":"6","key":"5237_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1158\/1535-7163.MCT-10-1010","volume":"10","author":"Q Liu","year":"2011","unstructured":"Liu Q, Liu L, Zhao Y, Zhang J, Wang D, Chen J, He Y, Wu J, Zhang Z, Liu Z: Hypoxia induces genomic DNA demethylation through the activation of HIF-1alpha and transcriptional upregulation of MAT2A in hepatoma cells. Mol Cancer Ther. 2011, 10 (6): 1113-1123. 10.1158\/1535-7163.MCT-10-1010.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"5237_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.acthis.2012.03.006","volume":"115","author":"T Zhang","year":"2013","unstructured":"Zhang T, Zheng Z, Liu Y, Zhang J, Zhao Y, Liu Y, Zhu H, Zhao G, Liang J, Li Q, Xu H: Overexpression of methionine adenosyltransferase II alpha (MAT2A) in gastric cancer and induction of cell cycle arrest and apoptosis in SGC-7901 cells by shRNA-mediated silencing of MAT2A gene. Acta Histochem. 2013, 115 (1): 48-55. 10.1016\/j.acthis.2012.03.006.","journal-title":"Acta Histochem"},{"issue":"1","key":"5237_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/j.gastro.2007.03.114","volume":"133","author":"H Chen","year":"2007","unstructured":"Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, Sodir NM, Chen YH, Josef-Lenz H, Laird PW, Clarke S, Mato JM, Lu SC: Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology. 2007, 133 (1): 207-218. 10.1053\/j.gastro.2007.03.114.","journal-title":"Gastroenterology"},{"key":"5237_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1756-9966-27-72","volume":"27","author":"Q Wang","year":"2008","unstructured":"Wang Q, Liu QY, Liu ZS, Qian Q, Sun Q, Pan DY: Inhibition of hepatocelluar carcinoma MAT2A and MAT2beta gene expressions by single and dual small interfering RNA. J Exp Clin Cancer Res. 2008, 27: 72-10.1186\/1756-9966-27-72.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"5237_CR27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1021\/cb3005353","volume":"8","author":"W Zhang","year":"2013","unstructured":"Zhang W, Sviripa V, Chen X, Shi J, Yu T, Hamza A, Ward ND, Kril LM, Vander Kooi CW, Zhan CG, Evers BM, Watt DS, Liu C: Fluorinated N, N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A. ACS Chem Biol. 2013, 8 (4): 796-803. 10.1021\/cb3005353.","journal-title":"ACS Chem Biol"},{"issue":"5","key":"5237_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molcel.2011.02.018","volume":"41","author":"Y Katoh","year":"2011","unstructured":"Katoh Y, Ikura T, Hoshikawa Y, Tashiro S, Ito T, Ohta M, Kera Y, Noda T, Igarashi K: Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein. Mol Cell. 2011, 41 (5): 554-566. 10.1016\/j.molcel.2011.02.018.","journal-title":"Mol Cell"},{"issue":"7363","key":"5237_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature10363","volume":"477","author":"C Frezza","year":"2011","unstructured":"Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, Jerby L, Micaroni M, Chaneton B, Adam J, Hedley A, Kalna G, Tomlinson IP, Pollard PJ, Watson DG, Deberardinis RJ, Shlomi T, Ruppin E, Gottlieb E: Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature. 2011, 477 (7363): 225-228. 10.1038\/nature10363.","journal-title":"Nature"},{"issue":"38","key":"5237_CR30","doi-asserted-by":"publisher","first-page":"33580","DOI":"10.1074\/jbc.M111.248401","volume":"286","author":"P Banerjee","year":"2011","unstructured":"Banerjee P, Basu A, Datta D, Gasser M, Waaga-Gasser AM, Pal S: The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. J Biol Chem. 2011, 286 (38): 33580-33590. 10.1074\/jbc.M111.248401.","journal-title":"J Biol Chem"},{"issue":"38","key":"5237_CR31","doi-asserted-by":"publisher","first-page":"32113","DOI":"10.1074\/jbc.M112.393140","volume":"287","author":"P Banerjee","year":"2012","unstructured":"Banerjee P, Basu A, Wegiel B, Otterbein LE, Mizumura K, Gasser M, Waaga-Gasser AM, Choi AM, Pal S: Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules. J Biol Chem. 2012, 287 (38): 32113-32123. 10.1074\/jbc.M112.393140.","journal-title":"J Biol Chem"},{"issue":"5","key":"5237_CR32","first-page":"1741","volume":"9","author":"Y Miyata","year":"2003","unstructured":"Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H: Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin Cancer Res. 2003, 9 (5): 1741-1749.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5237_CR33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.urology.2004.07.023","volume":"64","author":"B Tuna","year":"2004","unstructured":"Tuna B, Yorukoglu K, Gurel D, Mungan U, Kirkali Z: Significance of COX-2 expression in human renal cell carcinoma. Urology. 2004, 64 (6): 1116-1120. 10.1016\/j.urology.2004.07.023.","journal-title":"Urology"},{"key":"5237_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-94-007-4525-4_5","volume":"61","author":"K Igarashi","year":"2012","unstructured":"Igarashi K, Katoh Y: Metabolic aspects of epigenome: coupling of S-Adenosylmethionine synthesis and gene regulation on chromatin by SAMIT module. Subcell Biochem. 2012, 61: 105-118.","journal-title":"Subcell Biochem"},{"key":"5237_CR35","first-page":"91","volume":"67","author":"SK Kurdistani","year":"2011","unstructured":"Kurdistani SK: Histone modifications in cancer biology and prognosis. Prog Drug Res. 2011, 67: 91-106.","journal-title":"Prog Drug Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-196\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:08:37Z","timestamp":1630577317000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5237"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-196","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,17]]},"assertion":[{"value":"4 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"196"}}